Pediatrics Doctors in Alhambra, CA Accepting Medicare

10 Pediatrics doctors found. Showing 1 - 10

Dr. Tanya Thuy Nguyen, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 320 S Garfield Ave, Suite 288, Alhambra, CA 91801 Phone: 626-607-0288    Fax: 626-607-0399

Vivien Nite-dela Cruz,m.d., M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11 East Adams Avenue, Alhambra, CA 91801 Phone: 626-281-9037    Fax: 626-281-1186

Dr. Eva Mauer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 55 S Raymond Ave, Alhambra, CA 91801 Phone: 626-570-0723    Fax: 626-570-5639

Dr. Stuart Y Min, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 925 S Garfield Ave, Alhambra, CA 91801 Phone: 626-282-2829

Mr. Ming Long Shen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1000 South Garfield Ave, Alhambra, CA 91801 Phone: 626-281-3383

Dr. Marilyn Li, MD Pediatrics - Pediatric Allergy/Immunology Medicare: Medicare Enrolled Practice Location: 330 S Garfield Ave, Suite 116, Alhambra, CA 91801 Phone: 626-284-3400    Fax: 626-284-3434

Shobha Naimpally, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Bldg A-9, Alhambra, CA 91803 Phone: 626-299-3365

Mabel Yee, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1025 S Garfield Ave, Alhambra, CA 91801 Phone: 626-282-6166

Arthur Kong, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1048 S Garfield Ave Ste 100, Alhambra, CA 91801 Phone: 626-282-7585    Fax: 626-289-3211

May Y Lau, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 320 S Garfield Ave Ste 288, Alhambra, CA 91801 Phone: 626-607-0288    Fax: 626-607-0399

News Archive

FDA provides Orphan Drug Designation to Alnylam's ALN-TTR02

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. Food & Drug Administration (FDA) has provided Orphan Drug Designation to ALN-TTR02 as a therapeutic for the treatment of familial amyloidotic polyneuropathy (FAP), one of the predominant clinical manifestations of transthyretin (TTR)-mediated amyloidosis (ATTR).

Cardima receives Shonin approval from the Japanese MHLW to market PATHFINDER catheters

Cardima, Inc., a medical device company focused on the diagnosis and treatment of atrial fibrillation (AF), has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to re-enter the Japanese market with its family of guidewire-based, multi-electrode PATHFINDER® diagnostic mapping catheters.

Study looks at effectiveness of parity laws in reducing families' financial burdens

While the causes of autism continue to be debated and bandied about, real families who have children with autism spectrum disorders are left to struggle with expensive health care needs. These costs can be devastating - but they can also be markedly different if the family lives in Massachusetts or Maine.

Lux Biosciences receives CRL for Voclosporin

Isotechnika Pharma Inc. today announced that their partner, Lux Biosciences, Inc., has received a Complete Response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding their New Drug Application (NDA) for voclosporin. Lux's NDA, filed in February 2010, seeks approval for voclosporin in the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye.

Despite past disasters U.S. still not ready to cope biological attacks and flu pandemics

According to a newly released report the U.S. remains unprepared to deal with disasters such as biological attacks and flu pandemics.

Read more Medical News

› Verified 1 days ago